Genes in panel

Likely inborn error of metabolism - targeted testing not possible

Gene: GSTZ1

Amber List (moderate evidence)

GSTZ1 (glutathione S-transferase zeta 1)
EnsemblGeneIds (GRCh38): ENSG00000100577
EnsemblGeneIds (GRCh37): ENSG00000100577
OMIM: 603758, Gene2Phenotype
GSTZ1 is in 1 panel

2 reviews

Achchuthan Shanmugasundram (Genomics England Curator)

Green List (high evidence)

Comment on list classification: As reported in PMID:27876694 and reviewed by Saikat Santra, there are three boys and three girls with maleylacetoacetate isomerase deficiency (MAAID), identified by newborn screening with mildly elevated succinylacetone (SA) by mass spectrometry on dried blood spot.

Four of them were identified with homozygous GSTZ1 variants, one with compound heterozygous variants and one with heterozygous variant.

Hence, there is sufficient evidence available for the association of biallelic GSTZ1 variants with MAAID and this gene can be promoted to green rating in the next GMS review.
Created: 30 Jan 2024, 6:35 p.m. | Last Modified: 30 Jan 2024, 6:35 p.m.
Panel Version: 4.125
Comment on phenotypes: This gene has been associated with maleylacetoacetate isomerase deficiency in OMIM (MIM #617596), but not with any phenotypes in Gene2Phenotype.
Created: 30 Jan 2024, 6:29 p.m. | Last Modified: 30 Jan 2024, 6:29 p.m.
Panel Version: 4.124

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
[Maleylacetoacetate isomerase deficiency], OMIM:617596

Saikat Santra (Birmingham Children's Hospital)

Green List (high evidence)

GSTZ1 is established as the molecular cause for maleylacetoacetate isomerase deficiency which is an established inherited metabolic disorder and associated with succinylacetone excretion so may be detected on newborn screening programmes for hereditary tyrosinaemia type1 (FAH). The committee established for developing the pathways for rolling this out recommended that genetic testing for GSTZ1 be made available via the R98 panel to help evaluate patients with mild hypersuccinylacetonaemia - but patients with elevated succinylacetone on routine metabolic testing would also benefit from this being available.
Sources: Literature, Expert Review, Eligibility statement prior genetic testing
Created: 23 Jan 2024, 10:11 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Biochemical: hypersuccinylacetonaemia

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
Phenotypes
  • [Maleylacetoacetate isomerase deficiency], OMIM:617596
Tags
Q1_24_promote_green Q1_24_NHS_review
OMIM
603758
Clinvar variants
Variants in GSTZ1
Penetrance
unknown
Publications
Panels with this gene

History Filter Activity

30 Jan 2024, Gel status: 2

Entity classified by Genomics England curator

Achchuthan Shanmugasundram (Genomics England Curator)

Gene: gstz1 has been classified as Amber List (Moderate Evidence).

30 Jan 2024, Gel status: 0

Set Phenotypes

Achchuthan Shanmugasundram (Genomics England Curator)

Phenotypes for gene: GSTZ1 were changed from Biochemical to [Maleylacetoacetate isomerase deficiency], OMIM:617596

30 Jan 2024, Gel status: 0

Added Tag, Added Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag Q1_24_promote_green tag was added to gene: GSTZ1. Tag Q1_24_NHS_review tag was added to gene: GSTZ1.

23 Jan 2024, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set penetrance

Saikat Santra (Birmingham Children's Hospital)

gene: GSTZ1 was added gene: GSTZ1 was added to Likely inborn error of metabolism - targeted testing not possible. Sources: Literature,Expert Review,Eligibility statement prior genetic testing Mode of inheritance for gene: GSTZ1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: GSTZ1 were set to 27876694 Phenotypes for gene: GSTZ1 were set to Biochemical Penetrance for gene: GSTZ1 were set to unknown Review for gene: GSTZ1 was set to GREEN